Mamluk Roni

President & CEO at Ayala Pharmaceuticals, Inc.; Director at CHIASMA, INC

Sold, on record
$2.3M
Dollars the filings state
Form 4 sales
15
Latest Feb 24, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale CHIASMA, INCUnusual
    Jul 16, 2019 2019

    Sold 10,000 shares at $6.35 ($64k)

    Mamluk Roni, Director

    Sold 100% of holdings ($64k position)0 shares left4.2x usual sizeFiling

  2. 2 Form 4 sale CHIASMA, INCUnusual
    Sep 20, 2019 +66 days

    Sold 50,000 shares at $5.59 ($280k)

    Mamluk Roni, Director

    Sold 100% of holdings ($280k position)0 shares left13.5x usual sizeFiling

  3. 3 Form 4 sale CHIASMA, INCUnusual
    Oct 16, 2019 +26 days

    Sold 10,000 shares at $4.94 ($49k)

    Mamluk Roni, Director

    Sold 100% of holdings ($49k position)0 shares left2x usual sizeFiling

  4. 4 Form 4 sale CHIASMA, INCUnusual
    Dec 20, 2019 +65 days

    Sold 61,139 shares at $5.51 ($337k)

    Mamluk Roni, Director

    Sold 100% of holdings ($337k position)0 shares left8.2x usual sizeFiling

  5. 5 Form 4 sale CHIASMA, INCUnusual
    Feb 20, 2020 +62 days

    Sold 82,186 shares at $4.54 ($373k)

    Mamluk Roni, Director

    Sold 100% of holdings ($373k position)0 shares left8.2x usual sizeFiling

  6. 6 Form 4 sale Ayala Pharmaceuticals, Inc.Plan not stated
    Jan 21, 2021 +336 days

    Sold 20,872 shares at $15.03 ($314k)

    Mamluk Roni, President & CEO

    Sold 10.5% of holdings ($3M position)178,471 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale CHIASMA, INCUnusual
    Feb 9, 2021 +19 days

    Sold 27,981 shares at $5.00 ($140k)

    Mamluk Roni, Director

    Sold 100% of holdings ($140k position)0 shares left2.8x usual sizeFiling

  8. 8 Form 4 sale Ayala Pharmaceuticals, Inc.Plan not stated
    Feb 24, 2021 +15 days

    Sold 33,126 shares at $18.63 ($617k)

    Mamluk Roni, President & CEO

    Sold 18.6% of holdings ($3.3M position)145,345 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Mamluk Roni
Source
Feb 24, 2021Feb 24, 2021Ayala Pharmaceuticals, Inc.President & CEOForm 4 sale33,126$617k18.6%Plan not statedSEC
Feb 9, 2021Feb 11, 2021CHIASMA, INCDirectorForm 4 sale27,981$140k100.0%UnusualSEC
Jan 21, 2021Jan 22, 2021Ayala Pharmaceuticals, Inc.President & CEOForm 4 sale20,872$314k10.5%Plan not statedSEC
Feb 20, 2020Feb 21, 2020CHIASMA, INCDirectorForm 4 sale82,186$373k100.0%UnusualSEC
Dec 20, 2019Dec 23, 2019CHIASMA, INCDirectorForm 4 sale61,139$337k100.0%UnusualSEC
Oct 16, 2019Oct 17, 2019CHIASMA, INCDirectorForm 4 sale10,000$49k100.0%UnusualSEC
Sep 20, 2019Sep 23, 2019CHIASMA, INCDirectorForm 4 sale50,000$280k100.0%UnusualSEC
Jul 16, 2019Jul 17, 2019CHIASMA, INCDirectorForm 4 sale10,000$64k100.0%UnusualSEC
Apr 16, 2019Apr 17, 2019CHIASMA, INCDirectorForm 4 sale10,000$53k100.0%UnusualSEC
Mar 5, 2019Mar 6, 2019CHIASMA, INCDirectorForm 4 sale5,000$25k100.0%UnusualSEC
Jan 22, 2019Jan 23, 2019CHIASMA, INCDirectorForm 4 sale5,000$18k100.0%UnusualSEC
Jun 18, 2018Jun 20, 2018CHIASMA, INCDirectorForm 4 sale2,389$3k100.0%UnusualSEC
Mar 19, 2018Mar 20, 2018CHIASMA, INCDirectorForm 4 sale2,389$4k100.0%UnusualSEC
Dec 18, 2017Dec 19, 2017CHIASMA, INCDirectorForm 4 sale2,389$4k100.0%UnusualSEC
Oct 24, 2017Oct 26, 2017CHIASMA, INCDirectorForm 4 sale2,389$5k100.0%UnusualSEC